BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Mizuguchi Y, Takizawa T, Yoshida H, Uchida E. Dysregulated miRNA in progression of hepatocellular carcinoma: A systematic review. Hepatol Res. 2016;46:391-406. [PMID: 26490438 DOI: 10.1111/hepr.12606] [Cited by in Crossref: 65] [Cited by in F6Publishing: 67] [Article Influence: 9.3] [Reference Citation Analysis]
Number Citing Articles
1 Kou CH, Han J, Han XL, Zhuang HJ, Zhao ZM. Preparation and characterization of the Adriamycin-loaded amphiphilic chitosan nanoparticles and their application in the treatment of liver cancer. Oncol Lett 2017;14:7833-41. [PMID: 29344229 DOI: 10.3892/ol.2017.7210] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
2 Mao D, Chen H, Tang Y, Li J, Cao Y, Zhao J. Application of Isothermal Nucleic Acid Signal Amplification in the Detection of Hepatocellular Carcinoma-Associated MicroRNA. ChemPlusChem 2019;84:8-17. [DOI: 10.1002/cplu.201800382] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
3 Putri JF, Widodo N, Sakamoto K, Kaul SC, Wadhwa R. Induction of senescence in cancer cells by 5′-Aza-2′-deoxycytidine: Bioinformatics and experimental insights to its targets. Computational Biology and Chemistry 2017;70:49-55. [DOI: 10.1016/j.compbiolchem.2017.08.003] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.6] [Reference Citation Analysis]
4 Su R, Sun P, Zhang D, Xiao W, Feng C, Zhong L. Neuroprotective effect of miR-410-3p against sevoflurane anesthesia-induced cognitive dysfunction in rats through PI3K/Akt signaling pathway via targeting C–X–C motif chemokine receptor 5. Genes Genom 2019;41:1223-31. [DOI: 10.1007/s13258-019-00851-5] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 3.7] [Reference Citation Analysis]
5 Shen J, Wang Q, Gurvich I, Remotti H, Santella RM. Evaluating normalization approaches for the better identification of aberrant microRNAs associated with hepatocellular carcinoma. Hepatoma Res. 2016;2:305-315. [PMID: 28393113 DOI: 10.20517/2394-5079.2016.28] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
6 Wu X, Yang Y, Huang Y, Chen Y, Wang T, Wu S, Tong L, Wang Y, Lin L, Hao M, Zhong ZH, Zhang F, Zhao W. RNA-binding protein AUF1 suppresses miR-122 biogenesis by down-regulating Dicer1 in hepatocellular carcinoma. Oncotarget 2018;9:14815-27. [PMID: 29599909 DOI: 10.18632/oncotarget.24079] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
7 Mu B, Lv C, Liu Q, Yang H. Long non-coding RNA ZEB1-AS1 promotes proliferation and metastasis of hepatocellular carcinoma cells by targeting miR-299-3p/E2F1 axis. J Biochem 2021:mvab042. [PMID: 33788950 DOI: 10.1093/jb/mvab042] [Reference Citation Analysis]
8 Huang Y, Wang L, Chen Y, Han H, Li Q. Lipoic Acid-Modified Oligoethyleneimine-Mediated miR-34a Delivery to Achieve the Anti-Tumor Efficacy. Molecules 2021;26:4827. [PMID: 34443415 DOI: 10.3390/molecules26164827] [Reference Citation Analysis]
9 Shi DM, Bian XY, Qin CD, Wu WZ. miR-106b-5p promotes stem cell-like properties of hepatocellular carcinoma cells by targeting PTEN via PI3K/Akt pathway. Onco Targets Ther 2018;11:571-85. [PMID: 29416358 DOI: 10.2147/OTT.S152611] [Cited by in Crossref: 30] [Cited by in F6Publishing: 20] [Article Influence: 7.5] [Reference Citation Analysis]
10 Świtlik WZ, Bielecka-Kowalska A, Karbownik MS, Kordek R, Jabłkowski M, Szemraj J. Forms of diagnostic material as sources of miRNA biomarkers in hepatocellular carcinoma: a preliminary study. Biomark Med 2019;13:523-34. [PMID: 30854869 DOI: 10.2217/bmm-2018-0485] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
11 Wang J, Wang Z, Yuan J, Wang Q, Shen X. Upregulation of miR-137 Expression Suppresses Tumor Growth and Progression via Interacting with DNMT3a Through Inhibiting the PTEN/Akt Signaling in HCC. Onco Targets Ther 2021;14:165-76. [PMID: 33447058 DOI: 10.2147/OTT.S268570] [Reference Citation Analysis]
12 Yin LC, Xiao G, Zhou R, Huang XP, Li NL, Tan CL, Xie FJ, Weng J, Liu LX. MicroRNA-361-5p Inhibits Tumorigenesis and the EMT of HCC by Targeting Twist1. Biomed Res Int 2020;2020:8891876. [PMID: 33381597 DOI: 10.1155/2020/8891876] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
13 Cheng X, Chen M, Liu Z. MicroRNA-294 Promotes Cell Proliferation, Migration and Invasion in SMMC-7721 Hepatoma Carcinoma Cells by Activating the JNK/ERK Signaling Pathway. Am J Med Sci 2020;359:365-71. [PMID: 32498943 DOI: 10.1016/j.amjms.2020.03.009] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
14 Morishita A, Oura K, Tadokoro T, Fujita K, Tani J, Masaki T. MicroRNAs in the Pathogenesis of Hepatocellular Carcinoma: A Review. Cancers (Basel) 2021;13:514. [PMID: 33572780 DOI: 10.3390/cancers13030514] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 6.0] [Reference Citation Analysis]
15 Cui W, Li Y, Xu K, Chen G, Lu X, Duan Q, Kang Z. miR-361-5p inhibits hepatocellular carcinoma cell proliferation and invasion by targeting VEGFA. Biochem Biophys Res Commun 2016;479:901-6. [PMID: 27641667 DOI: 10.1016/j.bbrc.2016.09.076] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 2.7] [Reference Citation Analysis]
16 Zha Z, Jia F, Hu P, Mai E, Lei T. MicroRNA-574-3p inhibits the malignant behavior of liver cancer cells by targeting ADAM28. Oncol Lett 2020;20:3015-23. [PMID: 32782619 DOI: 10.3892/ol.2020.11852] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
17 Wei Y, Wang Z, Zong Y, Deng D, Chen P, Lu J. LncRNA MFI2-AS1 promotes HCC progression and metastasis by acting as a competing endogenous RNA of miR-134 to upregulate FOXM1 expression. Biomed Pharmacother. 2020;125:109890. [PMID: 32106369 DOI: 10.1016/j.biopha.2020.109890] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 7.5] [Reference Citation Analysis]
18 Sartorius K, Swadling L, An P, Makarova J, Winkler C, Chuturgoon A, Kramvis A. The Multiple Roles of Hepatitis B Virus X Protein (HBx) Dysregulated MicroRNA in Hepatitis B Virus-Associated Hepatocellular Carcinoma (HBV-HCC) and Immune Pathways. Viruses 2020;12:E746. [PMID: 32664401 DOI: 10.3390/v12070746] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
19 Li S, Huang Y, Fu Y, Tang D, Kang R, Zhou R, Fan XG. The long non-coding RNA TP73-AS1 modulates HCC cell proliferation through miR-200a-dependent HMGB1/RAGE regulation. J Exp Clin Cancer Res. 2017;36:51. [PMID: 28403886 DOI: 10.1186/s13046-017-0519-z] [Cited by in Crossref: 89] [Cited by in F6Publishing: 96] [Article Influence: 17.8] [Reference Citation Analysis]
20 Espelt MV, Bacigalupo ML, Carabias P, Troncoso MF. MicroRNAs contribute to ATP-binding cassette transporter- and autophagy-mediated chemoresistance in hepatocellular carcinoma. World J Hepatol 2019; 11(4): 344-358 [PMID: 31114639 DOI: 10.4254/wjh.v11.i4.344] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 2.7] [Reference Citation Analysis]
21 Zhou J, Chen L, Chen B, Huang S, Zeng C, Wu H, Chen C, Long F. Increased serum exosomal miR-134 expression in the acute ischemic stroke patients. BMC Neurol 2018;18:198. [PMID: 30514242 DOI: 10.1186/s12883-018-1196-z] [Cited by in Crossref: 29] [Cited by in F6Publishing: 31] [Article Influence: 7.3] [Reference Citation Analysis]
22 Jiang X, Shen X. Knockdown of miR-299-5p inhibits the progression of hepatocellular carcinoma by targeting SIAH1. Bull Cancer 2018;105:873-83. [PMID: 30266288 DOI: 10.1016/j.bulcan.2018.07.013] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
23 Chen QY, Des Marais T, Costa M. Deregulation of SATB2 in carcinogenesis with emphasis on miRNA-mediated control. Carcinogenesis 2019;40:393-402. [PMID: 30916759 DOI: 10.1093/carcin/bgz020] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
24 Zou W, Cheng J. MiR-887 Promotes the Progression of Hepatocellular Carcinoma via Targeting VHL. Technol Cancer Res Treat 2020;19:1533033820940425. [PMID: 32912113 DOI: 10.1177/1533033820940425] [Reference Citation Analysis]
25 Xu Z, Guo B, Chang P, Hui Q, Li W, Tao K. The Differential Expression of miRNAs and a Preliminary Study on the Mechanism of miR-194-3p in Keloids. Biomed Res Int 2019;2019:8214923. [PMID: 30956986 DOI: 10.1155/2019/8214923] [Cited by in Crossref: 2] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
26 Wong CM, Tsang FH, Ng IO. Non-coding RNAs in hepatocellular carcinoma: molecular functions and pathological implications. Nat Rev Gastroenterol Hepatol. 2018;15:137-151. [PMID: 29317776 DOI: 10.1038/nrgastro.2017.169] [Cited by in Crossref: 157] [Cited by in F6Publishing: 174] [Article Influence: 39.3] [Reference Citation Analysis]
27 Xing M, Xie X, Liu Z, Du X. Regulation of Tumorigenesis in Hepatocellular Carcinoma via the AKT3 Pathway in Cell Lines. Comput Math Methods Med 2021;2021:3267536. [PMID: 34745324 DOI: 10.1155/2021/3267536] [Reference Citation Analysis]
28 Huang J, Yang J, Lei Y, Gao H, Wei T, Luo L, Zhang F, Chen H, Zeng Q, Guo L. An ANCCA/PRO2000-miR-520a-E2F2 regulatory loop as a driving force for the development of hepatocellular carcinoma. Oncogenesis 2016;5:e229. [PMID: 27239961 DOI: 10.1038/oncsis.2016.22] [Cited by in Crossref: 12] [Cited by in F6Publishing: 15] [Article Influence: 2.0] [Reference Citation Analysis]
29 Zeng C, Yuan G, Hu Y, Wang D, Shi X, Zhu D, Hu A, Meng Y, Lu J. Repressing phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma by microRNA-142-3p restrains the progression of hepatocellular carcinoma. Bioengineered 2022;13:1491-506. [PMID: 34986757 DOI: 10.1080/21655979.2021.2020549] [Reference Citation Analysis]
30 Xiong J, Wang H, Mu F, Liu Z, Bao Y, Sun Y. MiR-125b-5p Inhibitor Might Protect Against Sevoflurane-induced Cognitive Impairments by Targeting LIMK1. Curr Neurovasc Res 2019;16:382-91. [PMID: 31490755 DOI: 10.2174/1567202616666190906145936] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
31 Xu B, Xu T, Liu H, Min Q, Wang S, Song Q. MiR-490-5p Suppresses Cell Proliferation and Invasion by Targeting BUB1 in Hepatocellular Carcinoma Cells. Pharmacology 2017;100:269-82. [PMID: 28810242 DOI: 10.1159/000477667] [Cited by in Crossref: 28] [Cited by in F6Publishing: 30] [Article Influence: 5.6] [Reference Citation Analysis]
32 Ding H, Ye ZH, Wen DY, Huang XL, Zeng CM, Mo J, Jiang YQ, Li JJ, Cai XY, Yang H, Chen G. Downregulation of miR‑136‑5p in hepatocellular carcinoma and its clinicopathological significance. Mol Med Rep 2017;16:5393-405. [PMID: 28849100 DOI: 10.3892/mmr.2017.7275] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
33 Yao X, Zhang H, Liu Y, Liu X, Wang X, Sun X, Cheng Y. miR-99b-3p promotes hepatocellular carcinoma metastasis and proliferation by targeting protocadherin 19. Gene 2019;698:141-9. [PMID: 30849536 DOI: 10.1016/j.gene.2019.02.071] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
34 El-Mahdy HA, Sallam AM, Ismail A, Elkhawaga SY, Elrebehy MA, Doghish AS. miRNAs inspirations in hepatocellular carcinoma: Detrimental and favorable aspects of key performers. Pathol Res Pract 2022;233:153886. [PMID: 35405621 DOI: 10.1016/j.prp.2022.153886] [Reference Citation Analysis]
35 Chen Y, Tang W, Liu C, Lin J, Wang Y, Zhang S, Chen G, Zheng X. miRNA-146a rs2910164 C>G polymorphism increased the risk of esophagogastric junction adenocarcinoma: a case-control study involving 2,740 participants. Cancer Manag Res 2018;10:1657-64. [PMID: 29983589 DOI: 10.2147/CMAR.S165921] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
36 Yin L, Keeler GD, Zhang Y, Hoffman BE, Ling C, Qing K, Srivastava A. AAV3-miRNA vectors for growth suppression of human hepatocellular carcinoma cells in vitro and human liver tumors in a murine xenograft model in vivo. Gene Ther 2021;28:422-34. [PMID: 32152434 DOI: 10.1038/s41434-020-0140-1] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
37 Shehab-Eldeen S, Nada A, Abou-Elela D, El-Naidany S, Arafat E, Omar T. Diagnostic Performance of microRNA-122 and microRNA-224 in Hepatitis C Virus-Induced Hepatocellular Carcinoma (HCC). Asian Pac J Cancer Prev 2019;20:2515-22. [PMID: 31450927 DOI: 10.31557/APJCP.2019.20.8.2515] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
38 Zhu C, Huang Q, Zhu H. Melatonin Inhibits the Proliferation of Gastric Cancer Cells Through Regulating the miR-16-5p-Smad3 Pathway. DNA Cell Biol 2018;37:244-52. [PMID: 29359963 DOI: 10.1089/dna.2017.4040] [Cited by in Crossref: 30] [Cited by in F6Publishing: 32] [Article Influence: 7.5] [Reference Citation Analysis]
39 Liang HW, Ye ZH, Yin SY, Mo WJ, Wang HL, Zhao JC, Liang GM, Feng ZB, Chen G, Luo DZ. A comprehensive insight into the clinicopathologic significance of miR-144-3p in hepatocellular carcinoma. Onco Targets Ther 2017;10:3405-19. [PMID: 28744145 DOI: 10.2147/OTT.S138143] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 2.8] [Reference Citation Analysis]
40 Yen CS, Su ZR, Lee YP, Liu IT, Yen CJ. miR-106b promotes cancer progression in hepatitis B virus-associated hepatocellular carcinoma. World J Gastroenterol 2016; 22(22): 5183-5192 [PMID: 27298561 DOI: 10.3748/wjg.v22.i22.5183] [Cited by in CrossRef: 37] [Cited by in F6Publishing: 35] [Article Influence: 6.2] [Reference Citation Analysis]
41 Oshiba RT, Touson E, Elsherbini YM, Abdraboh ME. Melatonin: A regulator of the interplay between FoxO1, miR96, and miR215 signaling to diminish the growth, survival, and metastasis of murine adenocarcinoma. Biofactors 2021. [PMID: 34058789 DOI: 10.1002/biof.1758] [Reference Citation Analysis]
42 Khare S, Khare T, Ramanathan R, Ibdah JA. Hepatocellular Carcinoma: The Role of MicroRNAs. Biomolecules 2022;12:645. [DOI: 10.3390/biom12050645] [Reference Citation Analysis]
43 Shimagaki T, Yoshizumi T, Harimoto N, Yoshio S, Naito Y, Yamamoto Y, Ochiya T, Yoshida Y, Kanto T, Maehara Y. MicroRNA-125b expression and intrahepatic metastasis are predictors for early recurrence after hepatocellular carcinoma resection. Hepatol Res. 2018;48:313-321. [PMID: 28984009 DOI: 10.1111/hepr.12990] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 3.0] [Reference Citation Analysis]
44 Zhu S, Rooney S, Michlewski G. RNA-Targeted Therapies and High-Throughput Screening Methods. Int J Mol Sci 2020;21:E2996. [PMID: 32340368 DOI: 10.3390/ijms21082996] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 4.5] [Reference Citation Analysis]
45 Liu W, Yin C, Liu Y. Circular RNA circ_0091579 Promotes Hepatocellular Carcinoma Proliferation, Migration, Invasion, and Glycolysis Through miR-490-5p/CASC3 Axis. Cancer Biother Radiopharm 2020. [PMID: 32673066 DOI: 10.1089/cbr.2019.3472] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
46 Czerwiński M, Bednarska-Czerwińska A, Ordon P, Gradzik M, Oplawski M, Boroń D, Zientek H, Ogloszka O, Grabarek BO. Variances in the Expression of mRNAs and miRNAs Related to the Histaminergic System in Endometrioid Endometrial Cancer. Biomedicines 2021;9:1535. [PMID: 34829764 DOI: 10.3390/biomedicines9111535] [Reference Citation Analysis]
47 Zhao D, Zhao J, Sun J, Su Y, Jian J, Ye H, Lin J, Yang Z, Feng J, Wang Z. The expression level of miR-155 in plasma and peripheral blood mononuclear cells in coronary artery disease patients and the associations of these levels with the apoptosis rate of peripheral blood mononuclear cells. Exp Ther Med 2018;16:4373-8. [PMID: 30542386 DOI: 10.3892/etm.2018.6797] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
48 Shiu TY, Lin HH, Shih YL, Feng AC, Huang HH, Huang TY, Hsieh CB, Chang WK, Hsieh TY. CRNDE-h transcript/miR-136-5p axis regulates interleukin enhancer binding factor 2 expression to promote hepatocellular carcinoma cell proliferation. Life Sci 2021;:119708. [PMID: 34153299 DOI: 10.1016/j.lfs.2021.119708] [Reference Citation Analysis]
49 Zhang P, Zhou HX, Yang MX, Wang Y, Cao WM, Lu KF, Wu RQ. WITHDRAWN: miR-543 promotes proliferation and invasion of non-small cell lung cancer cells by inhibiting PTEN. Biochem Biophys Res Commun 2016:S0006-291X(16)30478-8. [PMID: 27040768 DOI: 10.1016/j.bbrc.2016.03.157] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
50 Yang X, Cai JB, Peng R, Wei CY, Lu JC, Gao C, Shen ZZ, Zhang PF, Huang XY, Ke AW, Shi GM, Fan J. The long noncoding RNA NORAD enhances the TGF-β pathway to promote hepatocellular carcinoma progression by targeting miR-202-5p. J Cell Physiol 2019;234:12051-60. [PMID: 30537113 DOI: 10.1002/jcp.27869] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 4.8] [Reference Citation Analysis]
51 Shen J, Siegel AB, Remotti H, Wang Q, Santella RM. Identifying microRNA panels specifically associated with hepatocellular carcinoma and its different etiologies. Hepatoma Res. 2016;2:151-162. [PMID: 28243631 DOI: 10.20517/2394-5079.2015.66] [Cited by in Crossref: 7] [Cited by in F6Publishing: 10] [Article Influence: 1.2] [Reference Citation Analysis]
52 Wei XY, Ding J, Tian WG, Yu YC. MicroRNA-122 as a diagnostic biomarker for hepatocellular carcinoma related to hepatitis C virus: a meta-analysis and systematic review. J Int Med Res. 2020;48:300060520941634. [PMID: 32790532 DOI: 10.1177/0300060520941634] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
53 Tarek M, Louka ML, Khairy E, Ali-labib R, Zakaria Zaky D, Montasser IF. Role of microRNA-7 and selenoprotein P in hepatocellular carcinoma. Tumour Biol 2017;39:101042831769837. [DOI: 10.1177/1010428317698372] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
54 Zhang X, Xu X, Ge G, Zang X, Shao M, Zou S, Zhang Y, Mao Z, Zhang J, Mao F, Qian H, Xu W. miR‑498 inhibits the growth and metastasis of liver cancer by targeting ZEB2. Oncol Rep 2019;41:1638-48. [PMID: 30592286 DOI: 10.3892/or.2018.6948] [Cited by in Crossref: 12] [Cited by in F6Publishing: 27] [Article Influence: 3.0] [Reference Citation Analysis]
55 Xu T, Du XW, Hu JB, Zhu YF, Wu HL, Dai GP, Shu YM, Ouyang J. Anticancer effect of miR-96 inhibitor in bladder cancer cell lines. Oncol Lett 2018;15:3814-9. [PMID: 29467898 DOI: 10.3892/ol.2018.7745] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
56 Bi M, Chen W, Yu H, Wang J, Ding F, Tang DJ, Tang C. RETRACTED: miR-543 is up-regulated in gefitinib-resistant non-small cell lung cancer and promotes cell proliferation and invasion via phosphatase and tensin homolog. Biochemical and Biophysical Research Communications 2016;480:369-74. [DOI: 10.1016/j.bbrc.2016.10.055] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 3.2] [Reference Citation Analysis]
57 Zhuang LK, Yang YT, Ma X, Han B, Wang ZS, Zhao QY, Wu LQ, Qu ZQ. MicroRNA-92b promotes hepatocellular carcinoma progression by targeting Smad7 and is mediated by long non-coding RNA XIST. Cell Death Dis. 2016;7:e2203. [PMID: 27100897 DOI: 10.1038/cddis.2016.100] [Cited by in Crossref: 117] [Cited by in F6Publishing: 120] [Article Influence: 19.5] [Reference Citation Analysis]
58 Huang XY, Huang ZL, Xu YH, Zheng Q, Chen Z, Song W, Zhou J, Tang ZY, Huang XY. Comprehensive circular RNA profiling reveals the regulatory role of the circRNA-100338/miR-141-3p pathway in hepatitis B-related hepatocellular carcinoma. Sci Rep. 2017;7:5428. [PMID: 28710406 DOI: 10.1038/s41598-017-05432-8] [Cited by in Crossref: 119] [Cited by in F6Publishing: 128] [Article Influence: 23.8] [Reference Citation Analysis]
59 Pépin G, Ferrand J, Gantier MP. Assessing the Off-Target Effects of miRNA Inhibitors on Innate Immune Toll-Like Receptors. Methods Mol Biol 2017;1517:127-35. [PMID: 27924479 DOI: 10.1007/978-1-4939-6563-2_9] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
60 Nagoor Meeran MF, Goyal SN, Suchal K, Sharma C, Patil CR, Ojha SK. Pharmacological Properties, Molecular Mechanisms, and Pharmaceutical Development of Asiatic Acid: A Pentacyclic Triterpenoid of Therapeutic Promise. Front Pharmacol 2018;9:892. [PMID: 30233358 DOI: 10.3389/fphar.2018.00892] [Cited by in Crossref: 34] [Cited by in F6Publishing: 30] [Article Influence: 8.5] [Reference Citation Analysis]
61 Tao J, Jiang L, Chen X. Roles of microRNA in liver cancer. Liver Research 2018;2:61-72. [DOI: 10.1016/j.livres.2018.06.002] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.8] [Reference Citation Analysis]
62 Sartorius K, Makarova J, Sartorius B, An P, Winkler C, Chuturgoon A, Kramvis A. The Regulatory Role of MicroRNA in Hepatitis-B Virus-Associated Hepatocellular Carcinoma (HBV-HCC) Pathogenesis. Cells 2019;8:E1504. [PMID: 31771261 DOI: 10.3390/cells8121504] [Cited by in Crossref: 23] [Cited by in F6Publishing: 25] [Article Influence: 7.7] [Reference Citation Analysis]
63 Li Z, Lan Y, Zhao K, Lv X, Ding N, Lu H, Zhang J, Yue H, Shi J, Song D, Gao F, He W. miR-142-5p Disrupts Neuronal Morphogenesis Underlying Porcine Hemagglutinating Encephalomyelitis Virus Infection by Targeting Ulk1. Front Cell Infect Microbiol 2017;7:155. [PMID: 28516065 DOI: 10.3389/fcimb.2017.00155] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 2.4] [Reference Citation Analysis]
64 Zhou T, Li LF. Roles and mechanisms of action of microRNAs in colorectal cancer. Shijie Huaren Xiaohua Zazhi 2016; 24(22): 3362-3372 [DOI: 10.11569/wcjd.v24.i22.3362] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
65 Peng N, Miao Z, Wang L, Liu B, Wang G, Guo X. MiR-378 promotes the cell proliferation of osteosarcoma through down-regulating the expression of Kruppel-like factor 9. Biochem Cell Biol 2018;96:515-21. [PMID: 29490146 DOI: 10.1139/bcb-2017-0186] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 2.3] [Reference Citation Analysis]
66 Dong X, Ding W, Ye J, Yan D, Xue F, Xu L, Yin J, Guo W. MiR-24-3p enhances cell growth in hepatocellular carcinoma by targeting metallothionein 1M. Cell Biochem Funct 2016;34:491-6. [PMID: 27650047 DOI: 10.1002/cbf.3213] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 2.3] [Reference Citation Analysis]
67 Wang J, Song W, Shen W, Yang X, Sun W, Qu S, Shang R, Ma B, Pu M, Tao K. MicroRNA-200a Suppresses Cell Invasion and Migration by Directly Targeting GAB1 in Hepatocellular Carcinoma. Oncol Res. 2017;25:1-10. [PMID: 28081727 DOI: 10.3727/096504016x14685034103798] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 2.8] [Reference Citation Analysis]
68 Tian J, Zhao Y, Li L, Cui Y, Wu Y. MicroRNA-936 Targets JAG1 and Inhibits the Proliferation of Hepatocellular Carcinoma Cells. Technol Cancer Res Treat 2021;20:1533033820985785. [PMID: 33550933 DOI: 10.1177/1533033820985785] [Reference Citation Analysis]
69 Mao Y, Ding Z, Jiang M, Yuan B, Zhang Y, Zhang X. Circ_0091579 exerts an oncogenic role in hepatocellular carcinoma via mediating miR-136-5p/TRIM27. Biomed J 2021:S2319-4170(21)00181-5. [PMID: 34974169 DOI: 10.1016/j.bj.2021.12.009] [Reference Citation Analysis]
70 Wang L, Zheng M, Wu S, Niu Z. MicroRNA-188-3p is involved in sevoflurane anesthesia-induced neuroapoptosis by targeting MDM2. Mol Med Rep 2018;17:4229-36. [PMID: 29344658 DOI: 10.3892/mmr.2018.8437] [Cited by in Crossref: 3] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
71 Tuo H, Wang Y, Wang L, Yao B, Li Q, Wang C, Liu Z, Han S, Yin G, Tu K, Liu Q. MiR-324-3p promotes tumor growth through targeting DACT1 and activation of Wnt/β-catenin pathway in hepatocellular carcinoma. Oncotarget 2017;8:65687-98. [PMID: 29029464 DOI: 10.18632/oncotarget.20058] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 4.8] [Reference Citation Analysis]
72 Huang KT, Kuo IY, Tsai MC, Wu CH, Hsu LW, Chen LY, Kung CP, Cheng YF, Goto S, Chou YW, Chen CL, Lin CC, Chen KD. Factor VII-Induced MicroRNA-135a Inhibits Autophagy and Is Associated with Poor Prognosis in Hepatocellular Carcinoma. Mol Ther Nucleic Acids 2017;9:274-83. [PMID: 29246306 DOI: 10.1016/j.omtn.2017.10.002] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 2.6] [Reference Citation Analysis]
73 Tian W, Wang G, Liu Y, Huang Z, Zhang C, Ning K, Yu C, Shen Y, Wang M, Li Y, Wang Y, Zhang B, Zhao Y. RETRACTED: The miR-599 promotes non-small cell lung cancer cell invasion via SATB2. Biochemical and Biophysical Research Communications 2017;485:35-40. [DOI: 10.1016/j.bbrc.2017.02.005] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 4.6] [Reference Citation Analysis]